Condition: Intravitreal Injections · Sponsor: University Hospital Muenster
The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success. EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.
This description comes directly from the study's public registry record.
Nicole Eter, Prof. Dr. · 00492518356004 · eter@uni-muenster.de
Always discuss trial participation with your own doctor first.
| Klinikum Chemnitz gGmbH | Chemnitz, Saxony, Germany | Recruiting |
| Universitätsklinikum Aachen, AöR | Aachen, Germany | Recruiting |
| Universitätsmedizin Greifswald | Greifswald, Germany | Recruiting |
| Universität Leipzig | Leipzig, Germany | Recruiting |
| Universität Münster | Münster, Germany | Recruiting |
| Universitätsklinikum Tübingen | Tübingen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06810011